| Primary |
| Cardiac Stress Test |
18.7% |
| Supraventricular Tachycardia |
14.6% |
| Drug Use For Unknown Indication |
11.4% |
| Tachycardia |
7.3% |
| Hepatitis C |
5.7% |
| Diagnostic Procedure |
4.9% |
| General Anaesthesia |
4.1% |
| Scan Myocardial Perfusion |
4.1% |
| Surgery |
4.1% |
| Aneurysm Repair |
3.3% |
| Arrhythmia |
3.3% |
| Cardiac Arrest |
3.3% |
| Myocardial Ischaemia |
3.3% |
| Chest Pain |
2.4% |
| Coronary Artery Disease |
2.4% |
| Cardiac Pharmacologic Stress Test |
1.6% |
| Cardioversion |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Pneumonia |
1.6% |
| Angiogram |
0.8% |
|
| Respiratory Arrest |
19.1% |
| Medication Error |
7.4% |
| Wheezing |
7.4% |
| Bronchospasm |
5.9% |
| Tachycardia |
5.9% |
| Arteriospasm Coronary |
4.4% |
| Bradycardia |
4.4% |
| Drug Ineffective |
4.4% |
| Neurological Symptom |
4.4% |
| Procedural Complication |
4.4% |
| Respiratory Depression |
4.4% |
| Respiratory Distress |
4.4% |
| Asthma |
2.9% |
| Cardiac Arrest |
2.9% |
| Cardio-respiratory Arrest |
2.9% |
| Coronary Artery Stenosis |
2.9% |
| Cyanosis |
2.9% |
| Electrocardiogram St Segment Depression |
2.9% |
| Extravasation |
2.9% |
| Flushing |
2.9% |
|
| Secondary |
| Product Used For Unknown Indication |
18.2% |
| Supraventricular Tachycardia |
16.8% |
| Drug Use For Unknown Indication |
12.7% |
| Myocardial Ischaemia |
10.3% |
| Lower Respiratory Tract Infection |
7.4% |
| Pneumonia |
6.0% |
| Arrhythmia |
4.3% |
| Sinus Arrhythmia |
3.6% |
| Heart Rate Irregular |
2.6% |
| Tachycardia |
2.6% |
| Cardiac Stress Test |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.2% |
| Rheumatoid Arthritis |
1.9% |
| Atrial Flutter |
1.7% |
| Asthma |
1.4% |
| Hypertension |
1.4% |
| Meniere's Disease |
1.4% |
| Breast Cancer |
1.0% |
| Conjunctivitis Allergic |
1.0% |
| Her-2 Positive Breast Cancer |
1.0% |
|
| Supraventricular Tachycardia |
32.3% |
| Bronchospasm |
9.7% |
| Pulmonary Embolism |
8.1% |
| Cardiac Arrest |
4.8% |
| Drug Ineffective |
4.8% |
| Left Ventricular Dysfunction |
4.8% |
| Tachycardia |
4.8% |
| Tourette's Disorder |
4.8% |
| Arteriospasm Coronary |
3.2% |
| Basal Cell Carcinoma |
3.2% |
| Cardio-respiratory Arrest |
3.2% |
| Respiratory Depression |
3.2% |
| Angioedema |
1.6% |
| Condition Aggravated |
1.6% |
| Device Failure |
1.6% |
| Discomfort |
1.6% |
| Facial Pain |
1.6% |
| Heart Rate Irregular |
1.6% |
| Hypertension |
1.6% |
| Infusion Related Reaction |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.7% |
| Drug Use For Unknown Indication |
17.0% |
| Supraventricular Tachycardia |
6.5% |
| Pneumonia |
4.4% |
| Prophylaxis |
3.6% |
| Pulmonary Embolism |
3.5% |
| Pain |
3.4% |
| Nuclear Magnetic Resonance Imaging |
3.2% |
| Chemotherapy |
3.0% |
| Hypertension |
2.6% |
| Myocardial Ischaemia |
2.4% |
| Hepatitis C |
1.6% |
| Nuclear Magnetic Resonance Imaging Brain |
1.6% |
| Gastritis |
1.5% |
| Device Related Infection |
1.4% |
| Dizziness |
1.4% |
| Gastritis Erosive |
1.4% |
| Colitis Ulcerative |
1.4% |
| Lower Respiratory Tract Infection |
1.2% |
| Angiogram |
1.2% |
|
| Supraventricular Tachycardia |
12.3% |
| Pulmonary Embolism |
7.9% |
| Toxic Epidermal Necrolysis |
7.0% |
| Pain |
6.1% |
| Rash |
6.1% |
| Renal Failure Acute |
5.3% |
| Tachycardia |
5.3% |
| Vomiting |
5.3% |
| Dizziness |
4.4% |
| Haemoglobin Decreased |
4.4% |
| Renal Disorder |
4.4% |
| Anhedonia |
3.5% |
| Blood Thyroid Stimulating Hormone Increased |
3.5% |
| Condition Aggravated |
3.5% |
| Drug Ineffective |
3.5% |
| Enterocolitis |
3.5% |
| Muscle Spasms |
3.5% |
| Myositis |
3.5% |
| Nausea |
3.5% |
| Pneumonia |
3.5% |
|
| Interacting |
| Tachycardia |
85.7% |
| Atrial Tachycardia |
14.3% |
|
| Supraventricular Tachycardia |
42.9% |
| Tachycardia |
42.9% |
| Potentiating Drug Interaction |
14.3% |
|
